U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07338227) titled 'Validation of Clara Cell Protein as a Novel Diagnostic Biomarker for the Differentiation of Cardiogenic Pulmonary Edema From Non-Cardiogenic Pulmonary Edema' on Jan. 03.
Brief Summary: This study aimed to validate the use of clara cell secretory protein (CC16) as a biomarker for differentiating between cardiogenic pulmonary edema (CPE) and non-cardiogenic pulmonary edema (NCPE).
Study Start Date: Jan. 01, 2023
Study Type: OBSERVATIONAL
Condition:
Clara Cell Protein
Diagnostic Biomarker
Differentiation
Cardiogenic Pulmonary Edema
Non-Cardiogenic Pulmonary Edema
Intervention:
OTHER: Clara cell protein 16
Clara cell protein 16 (...